Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study
Nopaorn Phavichitr, Shugui Wang, Sirinuch Chomto, Ruangvith Tantibhaedhyangkul, Alexia Kakourou, Sukkrawan Intarakhao, Sungkom Jongpiputvanich, COLOR Study Group, Guus Roeselers, Jan Knol, Anundorn Wongteerasut, Kaouther Ben-Amor, Rocio Martin, Steven Ting, Orapa Suteerojntrakool, Chonikarn Visuthranukul, Punnapatch Piriyanon, Nopaorn Phavichitr, Shugui Wang, Sirinuch Chomto, Ruangvith Tantibhaedhyangkul, Alexia Kakourou, Sukkrawan Intarakhao, Sungkom Jongpiputvanich, COLOR Study Group, Guus Roeselers, Jan Knol, Anundorn Wongteerasut, Kaouther Ben-Amor, Rocio Martin, Steven Ting, Orapa Suteerojntrakool, Chonikarn Visuthranukul, Punnapatch Piriyanon
Abstract
Human milk is considered the optimal nutrition for infants and found to contain significant numbers of viable bacteria. The aim of the study was to assess the effects of a specific synbiotic combination at doses closer to the bacterial cells present in human milk, on intestinal bifidobacteria proportions (relative abundance), reduction of potential pathogens and gut physiological conditions. A clinical study was conducted in 290 healthy infants aged from 6 to 19 weeks. Infants received either a control infant formula or one of the two investigational infant formulas (control formula with 0.8 g/100 ml scGOS/lcFOS and Bifidobacterium breve M-16V at either 1 × 104 cfu/ml or 1 × 106 cfu/ml). Exclusively breastfed infants were included as a reference. Analyses were performed on intention-to-treat groups and all-subjects-treated groups. After 6 weeks of intervention, the synbiotics at two different doses significantly increased the bifidobacteria proportions in healthy infants. The synbiotic supplementation also decreased the prevalence (infants with detectable levels) and the abundance of C. difficile. Closer to the levels in the breastfed reference group, fecal pH was significantly lower while L-lactate concentrations and acetate proportions were significantly higher in the synbiotic groups. All formulas were well tolerated and all groups showed a comparable safety profile based on the number and severity of adverse events and growth. In healthy infants, supplementation of infant-type bifidobacterial strain B. breve M-16V, at a dose close to bacterial numbers found in human milk, with scGOS/lcFOS (9:1) created a gut environment closer to the breastfed reference group. This specific synbiotic mixture may also support gut microbiota resilience during early life.Clinical Trial Registration This clinical study named Color Synbiotics Study, was registered in ClinicalTrials.gov on 18 March 2013. Registration number is NCT01813175. https://ichgcp.net/clinical-trials-registry/NCT01813175 .
Conflict of interest statement
This study was financially supported by Danone Nutricia Research. Shugui Wang, Alexia Kakourou, Guus Roeselers, and Jan Knol are employees of Danone Nutricia Research. Nopaorn Phavichitr, Sirinuch Chomto, Ruangvith Tantibhaedhyangkul, Sukkrawan Intarakhao, Sungkom Jongpiputvanich, Orapa Suteerojntrakool, Chonikarn Visuthranukul, Anundorn Wongteerasut and Punnapatch Piriyanon declare no competing interests.
Figures
References
- Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–547. doi: 10.1038/nature09646.
- Huda MN, et al. Stool microbiota and vaccine responses of infants. Pediatrics. 2014;134(2):e362–372. doi: 10.1542/peds.2013-3937.
- Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J. Pediatr. Gastroenterol. Nutr. 2012;55(3):321–332. doi: 10.1097/MPG.0b013e31824fb899.
- Lewis ZT, Mills DA. Differential establishment of bifidobacteria in the breastfed infant Ggut. Nestle Nutr. Inst. Workshop Series. 2017;88:149–159. doi: 10.1159/000455399.
- Tannock GW, Lee PS, Wong KH, Lawley B. Why don't all infants have bifidobacteria in their stool? Front. Microbiol. 2016;7:834. doi: 10.3389/fmicb.2016.00834.
- Kumar, H. et al. The bifidogenic effect revisited—ecology and health perspectives of bifidobacterial colonization in early life. Microorganisms8(12), 1855. 10.3390/microorganisms8121855 (2020).
- Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr. Infect. Dis. J. 2019;28(2):145–146. doi: 10.1097/INF.0b013e318198c984.
- Lee SH, Gong YN, Ryoo E. Clostridium difficile colonization and/or infection during infancy and the risk of childhood allergic diseases. Korean J. Pediatr. 2017;60(5):145–150. doi: 10.3345/kjp.2017.60.5.145.
- Shamir R. The benefits of breast feeding. Nestle Nutr. Inst. Workshop Series. 2016;86:67–76. doi: 10.1159/000442724.
- Turck D, et al. Breastfeeding: Health benefits for child and mother. Arch. Pediatr. Organe Off. Soc. Francaise Pediatr. 2013;20:S29–48.
- Martin R, et al. Human milk is a source of lactic acid bacteria for the infant gut. J. Pediatr. 2003;143(6):754–758. doi: 10.1016/j.jpeds.2003.09.028.
- Perez PF, et al. Bacterial imprinting of the neonatal immune system: Lessons from maternal cells? Pediatrics. 2007;119(3):e724–732. doi: 10.1542/peds.2006-1649.
- Fernandez L, et al. The microbiota of human milk in healthy women. Cell Mol. Biol. 2013;59(1):31–42.
- Heikkila MP, Saris PE. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J. Appl. Microbiol. 2003;95(3):471–478. doi: 10.1046/j.1365-2672.2003.02002.x.
- Damaceno QS, Souza JP, Nicoli JR, et al. Evaluation of potential probiotics isolated from human milk and colostrum. Probiot. Antimicrob. Proteins. 2017;9(4):371–379. doi: 10.1007/s12602-017-9270-1.
- Boix-Amoros A, Collado MC, Mira A. Relationship between milk microbiota, bacterial load, macronutrients, and human cells during lactation. Front. Microbiol. 2016;7:492. doi: 10.3389/fmicb.2016.00492.
- Collado MC, Delgado S, Maldonado A, Rodriguez JM. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Lett. Appl. Microbiol. 2009;48(5):523–528. doi: 10.1111/j.1472-765X.2009.02567.x.
- Martin R, et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl. Environ. Microbiol. 2009;75(4):965–969. doi: 10.1128/AEM.02063-08.
- Qian L, Song H, Cai W. Determination of Bifidobacterium and Lactobacillus in breast milk of healthy women by digital PCR. Beneficial Microb. 2016;7(4):559–569. doi: 10.3920/BM2015.0195.
- Soto A, et al. Lactobacilli and bifidobacteria in human breast milk: Influence of antibiotherapy and other host and clinical factors. J. Pediatr. Gastroenterol. Nutr. 2014;59(1):78–88. doi: 10.1097/MPG.0000000000000347.
- Sugahara H, Odamaki T, Hashikura N, Abe F, Xiao JZ. Differences in folate production by bifidobacteria of different origins. Biosci. Microb. Food Health. 2015;34(4):87–93. doi: 10.12938/bmfh.2015-003.
- Odamaki T, et al. Comparative genomics revealed genetic diversity and species/strain-level differences in carbohydrate metabolism of three probiotic bifidobacterial species. Int. J. Genom. 2015;2015:567809.
- Kolida S, Gibson GR. Synbiotics in health and disease. Ann. Rev. Food Sci. Technol. 2011;2:373–393. doi: 10.1146/annurev-food-022510-133739.
- Gurry T. Synbiotic approaches to human health and well-being. Microb. Biotechnol. 2017;10(5):1070–1073. doi: 10.1111/1751-7915.12789.
- Chua MC, et al. Effect of synbiotic on the gut microbiota of cesarean delivered infants: A randomized, double-blind, multicenter study. J. Pediatr. Gastroenterol. Nutr. 2017;65(1):102–106. doi: 10.1097/MPG.0000000000001623.
- van Aa LB, et al. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol. 2010;40(5):795–804.
- Ouwehand AC. A review of dose–responses of probiotics in human studies. Beneficial Microb. 2017;8(2):143–151. doi: 10.3920/BM2016.0140.
- Bakker-Zierikzee AM, et al. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br. J. Nutr. 2005;94(5):783–790. doi: 10.1079/BJN20051451.
- Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2005;71(5):2318–2324. doi: 10.1128/AEM.71.5.2318-2324.2005.
- Legendre P, Oksanen J, ter Braak CJF. Testing the significance of canonical axes in redundancy analysis. Methods Ecol. Evol. 2011;2(3):269–277. doi: 10.1111/j.2041-210X.2010.00078.x.
- O'Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol. 2016;7:925. doi: 10.3389/fmicb.2016.00925.
- Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. Human gut microbiota and bifidobacteria: From composition to functionality. Antonie Van Leeuwenhoek. 2008;94(1):35–50. doi: 10.1007/s10482-008-9232-4.
- Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sanchez B, Margolles A. Bifidobacteria and their health-promoting effects. Microbiol. Spectrum. 2017 doi: 10.1128/microbiolspec.BAD-0010-2016.
- Underwood MA, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J. Pediatr. 2013;163(6):1585–1591.e1589. doi: 10.1016/j.jpeds.2013.07.017.
- Bridgman SL, et al. Fecal short-chain fatty acid variations by breastfeeding status in infants at 4 months: Differences in relative versus absolute concentrations. Front. Nutr. 2017;4:11. doi: 10.3389/fnut.2017.00011.
- Wopereis H, et al. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development. J. Allergy Clin. Immunol. 2017;141(4):1334–1342.e5. doi: 10.1016/j.jaci.2017.05.054.
- Tunc VT, Camurdan AD, Ilhan MN, Sahin F, Beyazova U. Factors associated with defecation patterns in 0–24-month-old children. Eur. J. Pediatr. 2008;167(12):1357–1362. doi: 10.1007/s00431-008-0669-2.
- Infante DD, Segarra OO, Redecillas SS, Alvarez MM, Miserachs MM. Modification of stool's water content in constipated infants: management with an adapted infant formula. Nutr. J. 2011;10:55. doi: 10.1186/1475-2891-10-55.
- Valdes-Varela L, Hernandez-Barranco AM, Ruas-Madiedo P, Gueimonde M. Effect of Bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates. Front. Microbiol. 2016;7:738.
- Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P. The resilience of the intestinal microbiota influences health and disease. Nat. Rev. Microbiol. 2017;15(10):630–638. doi: 10.1038/nrmicro.2017.58.
- Baglatzi L, et al. Effect of infant formula containing a low dose of the probiotic Bifidobacterium lactis CNCM I-3446 on immune and gut functions in c-section delivered babies: A pilot study. Clin. Med. Insights. Pediatr. 2016;10:11–19. doi: 10.4137/CMPed.S33096.
Source: PubMed